A complete update to the hit book on the real physics at work in comic books, featuring more heroes, more villains, and more science Since 2001, James Kakalios has taught "Everything I Needed to Know About Physics I Learned from Reading Comic Books," a hugely popular university course that generated coast-to-coast media attention for its unique method of explaining complex physics concepts through comics. With The Physics of Superheroes, named one of the best science books of 2005 by Discover, he introduced his colorful approach to an even wider audience. Now Kakalios presents a totally updated, expanded edition that features even more superheroes and findings from the cutting edge of science. With three new chapters and completely revised throughout with a splashy, redesigned package, the book that explains why Spider-Man's webbing failed his girlfriend, the probable cause of Krypton's explosion, and the Newtonian physics at work in Gotham City is electrifying from cover to cover.

The Science of Reading: A Handbook brings together state-of-the-art reviews of reading research from leading names in the field, to create a highly authoritative, multidisciplinary overview of contemporary knowledge about reading and related skills. Provides comprehensive coverage of the subject, including theoretical approaches, reading processes, stage models of reading, cross-linguistic studies of reading, reading difficulties, the biology of reading, and reading instruction Divided into seven sections:Word Recognition Processes in Reading; Learning to Read and Spell; Reading Comprehension; Reading in Different Languages; Disorders of Reading and Spelling; Biological Bases of Reading; Teaching Reading Edited by well-respected senior figures in the field

The breadth of topics reflects Dawes's wide-ranging impact on psychological theory and empirical practice. The two themes of rationality and social responsibility feature heavily. The book serves as an overview of psychological science development in its struggle to reconcile what is true with what is good.

After decades of painstaking planning, NASA's first dedicated exoplanet detection mission, the Kepler space telescope, was launched in 2009 from Cape Canaveral. Kepler began a years-long mission of looking for Earth-like planets amongst the millions of stars in the northern constellations of Lyra and Cygnus. Kepler's successful launch meant that it was only a matter of time before we would know just how many Earth-like planets exist in our galaxy. A revolution in thinking about our place in the universe was about to occur, depending on what Kepler found. Are earths commonplace or rare? Are we likely to be alone in the universe? Only Kepler could start to answer these vexing questions. Universal Life provides a unique viewpoint on the epochal events of the last two decades and the excitement of what will transpire in the coming decades. Author Alan Boss's perspective on this story is unmatched. Boss is the Chair of NASA's Exoplanet Exploration Program Analysis Group, and was also on the Kepler Mission science team. Kepler proved that essentially every star in the night sky has a planetary system, and that most of these systems contain a habitable world, potentially capable of evolving and supporting life. Universal Life summarizes the current state of exoEarth knowledge, and also reveals what will happen next in the post-Kepler world, namely the narrowing of the search for habitable worlds to the stars that are the closest to Earth, those that offer the best chances for future ground- and space-based telescopes to search for, and detect, possible signs of life in their atmospheres. We have come far in the search for life beyond the Earth, but the most exciting phase is about to begin: we may soon be able to prove that we are not alone in the universe.

Accelerated Predictive Stability (APS): Fundamentals and Pharmaceutical Industry Practices provides coverage of both the fundamental principles and pharmaceutical industry applications of the APS approach. Fundamental chapters explain the scientific basis of the APS approach, while case study chapters from many innovative pharmaceutical companies provide a thorough overview of the current status of APS applications in the pharmaceutical industry. In addition, up-to-date experiences in utilizing APS data for regulatory submissions in many regions and countries highlight the potential of APS in support of registration stability testing for certain regulatory submissions. This book provides high level strategies for the successful implementation of APS in a pharmaceutical company. It offers scientists and regulators a comprehensive resource on how the pharmaceutical industry can enhance their understanding of a product's stability and predict drug expiry more accurately and quickly. - Provides a comprehensive, one-stop-shop resource for accelerated predictive stability (APS) - Presents the scientific basis of different APS models - Includes the applications and utilities of APS that are demonstrated through numerous case studies - Covers up-to-date regulatory experience